SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Mak, J. Zhou, L. C. S. Tan, W. L. Au, Y. Y. Sitoh, N. Kandiah, Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 5, 576

    CrossRef

  2. 2
    N. J. H. M. Gerrits, Y. D. Werf, M. Hofman, E. M. J. Foncke, M. Klein, H. W. Berendse, O. A. Heuvel, Gray matter differences contribute to variation in cognitive performance in Parkinson's disease, European Journal of Neurology, 2014, 21, 2
  3. 3
    J. Vincent Filoteo, Jason D. Reed, Irene Litvan, Deborah L. Harrington, Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease, Movement Disorders, 2014, 29, 3
  4. 4
    Bonnie E. Levin, Heather L. Katzen, Andrew Maudsley, Judith Post, Connie Myerson, Varan Govind, Fatta Nahab, Blake Scanlon, Aaron Mittel, Whole-Brain Proton MR Spectroscopic Imaging in Parkinson's Disease, Journal of Neuroimaging, 2014, 24, 1
  5. 5
    Gordon W. Duncan, Michael J. Firbank, John T. O'Brien, David J. Burn, Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?, Movement Disorders, 2013, 28, 4
  6. 6
    Patrick S. R. Davidson, Shaun P. Cook, Leslie McGhan, Thomas Bouchard, Richard Camicioli, Source memory in normal aging and Parkinson's disease, Journal of Neuropsychology, 2013, 7, 2
  7. 7
    D. Weintraub, N. Dietz, J. E. Duda, D. A. Wolk, J. Doshi, S. X. Xie, C. Davatzikos, C. M. Clark, A. Siderowf, Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease, Brain, 2012, 135, 1, 170

    CrossRef

  8. 8
    Kurt A Jellinger, Neurobiology of cognitive impairment in Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1451

    CrossRef

  9. 9
    Rizwan S Akhtar, Matthew B Stern, New concepts in the early and preclinical detection of Parkinson’s disease: therapeutic implications, Expert Review of Neurotherapeutics, 2012, 12, 12, 1429

    CrossRef

  10. 10
    P. L. Pan, W. Song, H. F. Shang, Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson’s disease, European Journal of Neurology, 2012, 19, 2
  11. 11
    Niels K. Focke, Gunther Helms, Sebstian Scheewe, Pia M. Pantel, Cornelius G. Bachmann, Peter Dechent, Jens Ebentheuer, Alexander Mohr, Walter Paulus, Claudia Trenkwalder, Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic parkinson syndrome and healthy controls, Human Brain Mapping, 2011, 32, 11
  12. 12
    Michele Poletti, Murat Emre, Ubaldo Bonuccelli, Mild cognitive impairment and cognitive reserve in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 8, 579

    CrossRef

  13. 13
    Peggy J Planetta, Janey Prodoehl, Daniel M Corcos, David E Vaillancourt, Use of MRI to monitor Parkinson’s disease, Neurodegenerative Disease Management, 2011, 1, 1, 67

    CrossRef

  14. 14
    Bogdan Draganski, Kailash P Bhatia, Brain structure in movement disorders: a neuroimaging perspective, Current Opinion in Neurology, 2010, 23, 4, 413

    CrossRef

  15. 15
    Alice Cronin-Golomb, Parkinson’s Disease as a Disconnection Syndrome, Neuropsychology Review, 2010, 20, 2, 191

    CrossRef

  16. 16
    G. Stennis Watson, James B. Leverenz, Profile of Cognitive Impairment in Parkinson's Disease, Brain Pathology, 2010, 20, 3
  17. 17
    Kurt A. Jellinger, Parkinson's Disease,